84 related articles for article (PubMed ID: 21290826)
1. [The interaction of NS3 protein of hepatitis C virus with polymethylen derivatives of nucleic bases].
Mukovnia AV; Komissarov VV; Kritsyn AM; Mit'kevich VA; Tunitskaia VL; Kochetkov SN
Mol Biol (Mosk); 2010; 44(6):1045-53. PubMed ID: 21290826
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
3. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
5. Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities.
Utama A; Shimizu H; Hasebe F; Morita K; Igarashi A; Shoji I; Matsuura Y; Hatsu M; Takamizawa K; Hagiwara A; Miyamura T
Virology; 2000 Aug; 273(2):316-24. PubMed ID: 10915602
[TBL] [Abstract][Full Text] [Related]
6. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
[TBL] [Abstract][Full Text] [Related]
8. Characterization of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) helicase activity and its modulation by CSFV RNA-dependent RNA polymerase.
Wen G; Xue J; Shen Y; Zhang C; Pan Z
Virus Res; 2009 Apr; 141(1):63-70. PubMed ID: 19185595
[TBL] [Abstract][Full Text] [Related]
9. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.
Jin L; Peterson DL
Arch Biochem Biophys; 1995 Oct; 323(1):47-53. PubMed ID: 7487072
[TBL] [Abstract][Full Text] [Related]
10. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
[TBL] [Abstract][Full Text] [Related]
11. Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.
Hesson T; Mannarino A; Cable M
Biochemistry; 2000 Mar; 39(10):2619-25. PubMed ID: 10704211
[TBL] [Abstract][Full Text] [Related]
12. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
13. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
15. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein.
Misialek S; Rajagopalan R; Stevens SK; Beigelman L; Seiwert SD; Kossen K
Anal Biochem; 2009 Nov; 394(1):138-40. PubMed ID: 19591800
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic properties of hepatitis C virus NS3-associated helicase.
Paolini C; De Francesco R; Gallinari P
J Gen Virol; 2000 May; 81(Pt 5):1335-45. PubMed ID: 10769077
[TBL] [Abstract][Full Text] [Related]
18. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
[TBL] [Abstract][Full Text] [Related]
19. A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.
Howe AY; Chase R; Taremi SS; Risano C; Beyer B; Malcolm B; Lau JY
Protein Sci; 1999 Jun; 8(6):1332-41. PubMed ID: 10386883
[TBL] [Abstract][Full Text] [Related]
20. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
